12 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 31522610 | Tandem RNA isolation reveals functional rearrangement of RNA-binding proteins on CDKN1B/p27Kip1 3'UTRs in cisplatin treated cells. | 2020 Jan | 1 |
2 | 30642385 | Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5. | 2019 Jan 14 | 4 |
3 | 28658519 | Synergistic effect of melatonin and ghrelin in preventing cisplatin-induced ovarian damage via regulation of FOXO3a phosphorylation and binding to the p27Kip1 promoter in primordial follicles. | 2017 Oct | 2 |
4 | 27314502 | Upregulation of p27Kip1 by demethylation sensitizes cisplatin-resistant human ovarian cancer SKOV3 cells. | 2016 Aug | 1 |
5 | 27591936 | Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells. | 2016 Nov 1 | 1 |
6 | 26213845 | eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation. | 2015 Sep 22 | 1 |
7 | 23397083 | Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs. | 2013 Mar | 1 |
8 | 20145152 | miR-181a and miR-630 regulate cisplatin-induced cancer cell death. | 2010 Mar 1 | 1 |
9 | 17602078 | Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program. | 2007 Jul 1 | 3 |
10 | 11734333 | Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells. | 2002 Jan 10 | 1 |
11 | 11593424 | Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells. | 2001 Sep 27 | 1 |
12 | 9688315 | Contribution of the cyclin-dependent kinase inhibitor p27KIP1 to the confluence-dependent resistance of HT29 human colon carcinoma cells. | 1998 Aug 31 | 1 |